 SAN CLEMENTE, CA ACCESSWIRE June 29, 2021 ReShape Lifesciences Inc. NASDAQ:RSLS, a global weight-loss solutions leader, announced today that it has entered into a warrant exercise agreement with existing accredited investors to exercise certain outstanding warrants to purchase up to an aggregate of 7.9 million shares of the companys common stock. In consideration for the immediate exercise of the existing warrants for cash, the exercising holders received new unregistered warrants to purchase up to an aggregate of 5.9 million shares equal to 75 of the shares of common stock issued in connection with the exercise of the companys common stock. 